Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

The obesity drug market has experienced a seismic shift in recent years, with Novo Nordisk's (NOV: N) Wegovy (semaglutide) ...

The Danish biotech’s recruitment drive began last summer when data from an early-stage trial of the drug—petrelintide—showed ...

Among the top mergers and acquisitions (M&As) last month was AstraZeneca’s billion-dollar buyout of Belgian biotech EsoBiotec. The startup has come up with its EsoBiotec Engineered NanoBody Lentiviral ...

Copenhagen, Denmark, March 27, 2025-Zealand Pharma A/S ("Zealand") (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

Given the extent of India’s pharma exports to US, this has created a certain bit of uncertainty in the market. Trump said the US would impose tariffs on autos, pharmaceuticals and aluminum in ...

Tariffs on pharmaceuticals would go against a duty-free agreement that the U.S. signed on to under the World Trade Organization, which barely held up during Trump’s first term. Under the 1994 ...

Investors and patients will have to wait sometime for such products to launch, however, with Zealand Pharma's CEO and President Adam Steensberg telling CNBC that he expects Petrelintide to come to ...

Sauvignon Blanc is one of the world’s favorite white wine varietals and has emerged as New Zealand’s signature grape. Below is a brief description and tasting notes on 15 of New Zealand’s ...

Analysts expect investor debates to now focus on competitive threats to petrelintide, the long-term obesity market outlook, and Zealand Pharma’s catalyst path. They see limited downside risk from ...